Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients (Q44130698)
Jump to navigation
Jump to search
scientific article published in October 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients |
scientific article published in October 2002 |
Statements
1 reference
Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients (English)
1 reference
1 reference
Rüdiger Hardeland
1 reference
Sonja Jacob
1 reference
Burkhard Poeggeler
1 reference
Jochen H Weishaupt
1 reference
Mathias Bähr
1 reference
1 October 2002
1 reference
1 reference
Identifiers
1 reference